■快速准确地诊断病原体对于可能引起败血症/脓毒性休克的血流感染(BSI)的临床管理至关重要。相当数量的疑似脓毒症患者最初通过急诊科(ED)进入医疗保健系统,因此,制定早期诊断脓毒症的策略并在ED中立即开始治疗至关重要.本研究旨在评估液滴数字PCR(ddPCR)在ED中可疑脓毒症患者的诊断性能和临床价值。
这是一项前瞻性单中心观察性研究,包括2022年10月25日至2023年6月3日接受ED的患者,通过改良Shapiro评分(MSS)评分筛查可疑BSI。进行ddPCR和血液培养(BC)之间的比较以评估ddPCR对BSI的诊断性能。同时,进行了ddPCR与炎症和预后相关生物标志物之间的相关性分析。Further,分析了ddPCR的卫生经济学评价。
■来自228名患者的258个样本,同时进行BC和ddPCR,包括在这项研究中。我们发现,在48.13%(214例中的103例)的发作中,ddPCR结果为阳性,鉴定出132种病原体。相比之下,BC只检测到18个阳性,其中88.89%通过ddPCR鉴定。当考虑经过文化验证的BSIs时,ddPCR显示总体灵敏度为88.89%,特异性为55.61%,通过ddPCR定量BSI的最佳诊断能力达到155.5的拷贝截止值.我们进一步发现ddPCR表现出很高的准确性,尤其是在肝脓肿患者中。在所有通过ddPCR鉴定的病毒中,EBV具有明显更高的阳性率,与免疫抑制有关。此外,ddPCR中病原体的拷贝与各种炎症标志物呈正相关,凝血,免疫以及预后。具有较高的敏感性和特异性,ddPCR促进了精确的抗菌管理并降低了医疗保健成本。
■多重ddPCR可提供病原体的精确和定量负荷数据,提供了监测患者病情的能力,并且可以在紧急的临床情况下作为脓毒症的早期预警。
早期发现和有效使用抗生素对于改善急诊科感染患者的临床预后至关重要。ddPCR,一种用于快速和敏感的病原体鉴定的新兴工具,用作精确的床边测试,已开发用于解决BSI诊断和精确治疗的当前挑战。它的特点是灵敏度,特异性,再现性,和没有标准曲线的绝对定量。ddPCR可以在3小时内检测可疑BSI患者的致病病原体和相关耐药基因。此外,它可以识别多种微生物BSIs并动态监测血液中病原微生物的变化,可用于评估抗生素疗效和生存预后。此外,ddPCR中病原体的拷贝与各种炎症标志物呈正相关,凝血,豁免权。具有较高的敏感性和特异性,ddPCR促进了精确的抗菌管理并降低了医疗保健成本。
UNASSIGNED: Rapid and accurate diagnosis of the causative agents is essential for clinical management of bloodstream infections (BSIs) that might induce sepsis/septic shock. A considerable number of suspected sepsis patients initially enter the health-care system through an emergency department (ED), hence it is vital to establish an early strategy to recognize sepsis and initiate prompt care in ED. This study aimed to evaluate the diagnostic performance and clinical value of droplet digital PCR (ddPCR) assay in suspected sepsis patients in the ED.
UNASSIGNED: This was a prospective single-centered observational study including patients admitted to the ED from 25 October 2022 to 3 June 2023 with suspected BSIs screened by Modified Shapiro Score (MSS) score. The comparison between ddPCR and blood culture (BC) was performed to evaluate the diagnostic performance of ddPCR for BSIs. Meanwhile, correlative analysis between ddPCR and the inflammatory and prognostic-related biomarkers were conducted to explore the relevance. Further, the health economic evaluation of the ddPCR was analyzed.
UNASSIGNED: 258 samples from 228 patients, with BC and ddPCR performed simultaneously, were included in this study. We found that ddPCR results were positive in 48.13% (103 of 214) of episodes, with identification of 132 pathogens. In contrast, BC only detected 18 positives, 88.89% of which were identified by ddPCR. When considering culture-proven BSIs, ddPCR shows an overall sensitivity of 88.89% and specificity of 55.61%, the optimal diagnostic power for quantifying BSI through ddPCR is achieved with a copy cutoff of 155.5. We further found that ddPCR exhibited a high accuracy especially in liver abscess patients. Among all the identified virus by ddPCR, EBV has a substantially higher positive rate with a link to immunosuppression. Moreover, the copies of pathogens in ddPCR were positively correlated with various markers of inflammation, coagulation, immunity as well as prognosis. With high sensitivity and specificity, ddPCR facilitates precision antimicrobial stewardship and reduces health care costs.
UNASSIGNED: The multiplexed ddPCR delivers precise and quantitative load data on the causal pathogen, offers the ability to monitor the patient\'s condition and may serve as early warning of sepsis in time-urgent clinical situations as ED.
UNASSIGNED: Early detection and effective administration of antibiotics are essential to improve clinical outcomes for those with life-threatening infection in the emergency department. ddPCR, an emerging tool for rapid and sensitive pathogen identification used as a precise bedside test, has developed to address the current challenges of BSI diagnosis and precise treatment. It characterizes sensitivity, specificity, reproducibility, and absolute quantifications without a standard curve. ddPCR can detect causative pathogens and related resistance genes in patients with suspected BSIs within a span of three hours. In addition, it can identify polymicrobial BSIs and dynamically monitor changes in pathogenic microorganisms in the blood and can be used to evaluate antibiotic efficacy and survival prognosis. Moreover, the copies of pathogens in ddPCR were positively correlated with various markers of inflammation, coagulation, immunity. With high sensitivity and specificity, ddPCR facilitates precision antimicrobial stewardship and reduces health care costs.